https://www.selleckchem.com/pr....oducts/Vorinostat-sa
The objective of the study was to analyze the oncological outcomes and prognostic factors in patients with early-stage juvenile granulosa cell tumor (JGCT) who underwent fertility-sparing surgery. All patients with early-stage JGCT who underwent fertility-sparing surgery between January 1995 and December 2017 were reviewed retrospectively. None. The risk factors for recurrence and death in patients with early-stage JGCT were identified. Thirty-five patients were eligible for the current study. The median age was 17 years (range
Beğen
Yorum Yap
Paylaş
